Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 372 results found. Search for [ Drug controller general of India ]

Results 1 to 21 of 372
BusinessToday.In
April 9, 2021
The committee asked the company to submit a comparative analysis of late-stage immunogenicity data from both its Indian studies and an ongoing Russian study.


BusinessToday.In
April 6, 2021
Shares of HDFC, Maruti Suzuki, SBI Cards, Panacea Biotec, Marico, Adani Ports, HDFC Bank, YES Bank, Bank of India, will be in focus on Tuesday's trade


BusinessToday.In
April 5, 2021
Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF.


BusinessToday.In
April 5, 2021
Over 91.15% of patients treated with PegIFN were found to be RT PCR negative by day 7 as compared to 78.90 per cent on the 'standard of care' arm; PegIFN reduced the duration for supplemental oxygen to 56 hours from 84 hours in moderate COVID-19 patients


BusinessToday.In
March 31, 2021
The Drug Controller General of India (DCGI) has allowed the extension of AstraZeneca coronavirus vaccine's expiration time period from the earlier prescribed six months


Rai Vinaykumar & Mudit Kapoor
March 13, 2021
India administered 1,87,55,540 first doses of the vaccine in the first 17 days of March. At this rate, it will take 2.36 years for India to vaccinate 70 per cent of its population with the initial dose of the two-dose regime vaccination programme.


BusinessToday.In
March 12, 2021
AstraZeneca Pharma share gained as much as 1.88 per cent to hit a high of Rs 3,480 after the drug maker received import and market permission from the DCGI for osimertinib tablets (Tagrisso) used in treatment of non-small cell lung cancer


BusinessToday.In
March 12, 2021
Stock Market News Update Today: Bajaj Auto, Maruti Suzuki, Sun Pharmaceutical Industries, Reliance Industries, UltraTech Cement were among top losers, while Power Grid Corporation, Titan, ONGC and Infosys were among notable gainers.


BusinessToday.In
March 12, 2021
Shares of Reliance, Infosys, HPCL, IDBI Bank, AstraZeneca, NMDC, V Mart, Happiest Minds Technologies will be in focus in Friday's trading session


BusinessToday.In
March 11, 2021
Price reduction may unlikely have any impact on final price charged from people vaccinating at private hospitals as Covid-19 vaccines are already subsidised by Centre


PTI
March 9, 2021
As of February 4, a total of 96.28 lakh healthcare workers and 78.51 lakh frontline workers have been identified for COVID-19 vaccination, Minister of State for Health Ashwini Choubey told the Rajya Sabha in a written reply


PTI
March 5, 2021
According to NCPCR, there is no uniformity in the testing methods used by labs to detect the presence of formaldehyde and asbestos in J&J's products


BusinessToday.In
March 1, 2021
The government, in this phase, will vaccinate people over 60 and individuals over 45 with comorbidities to rein in the rising number of more infectious virus strains leading to a spurt in COVID-19 cases in some states


PB Jayakumar
February 26, 2021
SS Innovations is planning to make 100 units this year of the multi arm novel 'Mantra' Surgical Robotic System indigenously developed over the last three years. Plans are to make and sell over 1,000 units within the next five years


BusinessToday.In
February 24, 2021
Balkrishna said that the medicines introduced during the press conference have been validated through in-depth in-vitro and in-vivo biological and chemical studies, along with randomised clinical trials


BusinessToday.In
February 23, 2021
Deshmukh's statements come a day after the Indian Medical Association (IMA) expressed shock over Patanjali's claims of getting WHO certification for Coronil tablets


PB Jayakumar
February 23, 2021
In the early days of COVID-19 outbreak last year, India relied on imports from leading medical companies like Roche Diagnostic, Korea's S.D Biosensor, Siemens Healthcare, Thermofisher, Abbott Healthcare, apart from Chinese and South Korean manufacturers


PTI
February 22, 2021
The company, which has its labs in England, had in early September 2020 received the approval from the Drug Controller General (DCGI) to conduct the phase 2 clinical trial of GPP-Baladol in patients with moderate infection of the pandemic with oxygen support


PB Jayakumar
February 22, 2021
The trial was conducted on 40 patients since November at BJ Government Medical College and Sassoon General Hospital Pune and Victoria Medical College and Research Institute, Bangalore


PB Jayakumar
February 19, 2021
The Government is yet to finalise a strategy for vaccinating 27 crore elderly in India in the next phase. The Government target was to vaccinate over three million people per day


PAGES 1 OF 19  12345